Alan Auerbach is the founder of Puma Biotechnology. Puma Biotechnology has raised $60M in total funding. Latest round: Series C.
Alan H. Auerbach is the Chief Executive Officer, President, and Chairman of the Board of Puma Biotechnology, a biopharmaceutical company focused on developing and commercializing novel therapeutics for cancer treatment. Prior to founding Puma, Mr. Auerbach was the Founder, CEO, President, and Board Member of Cougar Biotechnology, which was acquired by Johnson & Johnson in 2009. He previously worked as a Vice President, Senior Research Analyst at Wells Fargo Securities, covering small and mid-cap biotechnology companies with a focus on oncology.
Full founder directory · Investor directory · Company funding database · Fundraising library